INVO Fertility, Inc. (IVF): Nasdaq/NYSE listing notice — INVO Fertility receives Nasdaq deficiency notice for late 10-K filing

INVO Fertility, Inc.

Received Nasdaq notice on April 23, 2026, for failing to file 2025 Form 10-K by April 15, 2026.
Delay is due to complex accounting matters: tax provision, warrant accounting, and variable interest entity.
Company has 60 days to submit a compliance plan; Nasdaq may grant up to 180-day extension to October 13, 2026.
Stock continues trading on Nasdaq under symbol IVF; no immediate delisting effect.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

April 23, 2026, INVO Fertility, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company failed to fi

View on SEC.gov

19 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-019593

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.